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Human epidemiologic studies have shown a
relationship between ozone exposure and a
decrease in pulmonary function in both chil-
dren and adults (Balmes et al. 1997;
Gauderman et al. 2004; Hiltermann et al.
1998). O3 is produced through photo-
chemical reactions of volatile organic com-
pounds in the presence of nitrogen oxides
and sunlight. Exposure to O3 occurs primar-
ily through inhalation, and causes injury and
alterations to the respiratory tract. The
National Ambient Air Quality Standard for
O3 is set at 0.12 ppm [U.S. Environmental
Protection Agency (EPA) 2000], which is
often exceeded in urban areas during the
summer months. Inhaled O3 first reacts with
constituents of the epithelial lining fluid (e.g.,
micronutrient antioxidants such as ascorbate,
urate, and vitamin E) and unsaturated lipids
by reactive absorption. 
O3 reaction with these components of the
epithelial lining fluid produces reactive prod-
ucts including highly reactive aldehydes, hydro-
gen peroxide, superoxide, oxysterols, and
hydroxyl radicals (Connor et al. 2004; Pulfer
et al. 2005; Putman et al. 1997). Therefore,
cellular responses to O3 are rarely a result of the
direct reaction of O3 with cell surface compo-
nents, but are rather mediated through a cas-
cade of secondary products (Kelly et al. 1995;
Pryor 1994). The lung’s inflammatory cells,
such as macrophages, eosinophils, and neu-
trophils, constitute a major component of this
cascade. Upon activation, these cells generate
reactive oxygen and nitrogen species and cause
substantial injury to lipid membranes, intra-
cellular components, and proteins. In addition,
O3 exposure activates epithelial cells and
inflammatory cells to release cytokines,
chemokines, and arachidonic acid. Arachidonic
acid can be metabolized to leukotrienes (LTs),
prostaglandins (PGs) hydroxyeicosatetraenoic
acids (HETEs), dihydroxyeicosatetraenoic
acids, and other metabolites. 
Previous studies have examined acute O3
exposure as it relates to changes in eicosanoid
levels and other cellular mediators, such as
chemokines, cytokines, fibronectin and cell
adhesion molecules (Driscoll et al. 1993;
Ishii et al. 1997; Schlesinger et al. 1990).
Furthermore, van Bree et al. (2001) studied
the effects of exposure to 0.4 ppm O3 over
56 days in rats, and observed an acute inflam-
matory response characterized by an increase
in neutrophils, protein, and albumin in
bronchoalveolar lavage fluid (BALF) that
reached a maximum 1 day after exposure.
The acute inflammation resolved largely
within 6 days during ongoing exposure, with
neutrophils, protein, and albumin in BALF
returning to control levels. However, the
number of macrophages in BALF increased
throughout the study. In addition, the colla-
gen content in septa of the alveolar duct
increased with ongoing exposure, marking
the potential onset of fibrosis.
In the rat, long-term O3 exposure
(> 90 days) leads to tolerance to further O3
exposure and remodeling of the distal airways,
including an increase in nonciliated cell mass
and volume fraction in terminal bronchioles
and bronchiolarization of the alveolar duct
(Plopper et al. 1994a, 1994b). Long-term O3
exposure has also been shown to cause
increased sensitivity to the toxicity of the
nitroaromatic 1-nitronapthalene (1-NN).
Incomplete combustion of both gasoline and
diesel fuel results in numerous nitrated poly-
aromatic hydrocarbons present in both the
particulate- and gas-phase fractions of the
exhaust (Draper 1986; Ishihara 2003). In
addition, nitroaromatic compounds can be
formed by nitration of the parent hydro-
carbons through atmospheric reactions par-
tially driven by the presence of O3 (Atkinson
and Arey 1994). 
Although 1-NN causes both centrilobular
liver damage and bronchiolar epithelial dam-
age in rats, the lung is the primary target tissue.
At low and moderate doses, 1-NN causes an
acute inflammatory event in the lungs that can
be separated into two distinct temporal stages.
The first stage occurs within the first 2 hr of
exposure and is characterized by an increase in
Clara cell toxicity. Clara cells contain high lev-
els of cytochrome P450 monooxygenase 2B1,
which is responsible for the bioactivation of
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Ambient air is polluted with a mixture of pulmonary toxicants. Previous studies indicate that prior
exposure to atmospheric oxidant pollutants such as ozone may significantly alter the response to
other pollutants, such as 1-nitronaphthalene (1-NN). 1-NN, a component of the particulate
exhaust from diesel engines, has been found at low concentrations in ambient air. Using a
metabolomic approach, we investigated inflammatory responses in arachidonic and linoleic acid
biochemical cascades (35 metabolites) and the expression of 19 cytokines/chemokines at three
time points (2, 6, and 24 hr) following exposure to 1-NN with and without prior long-term
O3 exposure. Long-term O3 exposure is associated with biochemical changes that have been
shown to render the lung resistant to further O3 exposure. This study indicates that airways of
O3-tolerant rats exhibited a low level of chronic inflammation, rendering the lungs more suscepti-
ble to other environmental pollutants such as 1-NN. Specifically, a 12.5-mg/kg dose of 1-NN to
O3-tolerant rats produced significantly higher levels of cysteinyl-leukotrienes in bronchiolar lavage
fluid even when compared to a 50-mg/kg dose of 1-NN in rats exposed to filtered air. Collectively,
these results indicate that the combination of exposures as encountered in polluted ambient air are
considerably more injurious to the lung than would be anticipated from previous studies employing
single exposures. The observed synergism between O3 and 1-NN may be causally related to a shift
in a T-helper 1 to T-helper 2 immune response in the airways. Key words: 1-nitronaphthalene,
arachidonic acid, cyclooxygenase, inflammatory mediators, linoleic acid, lipoxygenase, ozone.
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1-NN in the rat airway (Verschoyle et al.
1993). Reactive metabolites become bound
covalently to cellular proteins; this process has
been implicated in pulmonary epithelial cell
injury associated with the high degree of P450
localization (Verschoyle et al. 1993; Wheelock
et al. 2005). Ciliated cells, which contain only
limited cytochrome P450 activity, are affected
when adjacent to Clara cells. The second stage
of 1-NN pulmonary inflammation occurs
within 6 hr of exposure and is marked by infil-
tration of inflammatory cells into the intersti-
tial areas and the onset of respiratory distress
syndrome (at high doses). The infiltration of
inflammatory cells into the lung is responsible
for further damage to tracheal and bronchiolar
epithelium. Sauer et al. (1997) correlated the
respiratory distress syndrome induced by
1-NN with the infiltration of neutrophils,
mononuclear cells, and small lymphocytes at
both 6 and 24 hr after 1-NN exposure.
In this study we investigated the difference
between the acute inflammatory responses
produced by 1-NN in the airway lumen of
rats following long-term O3 exposure versus
that of controls exposed to filtered air.
Moreover, our goal was to understand the
roles of inflammatory mediators in the previ-
ously recognized synergistic toxicity of O3 and
1-NN. An examination of inflammatory
mediators indicated both temporal- and dose-
dependent effects, providing insights into
alterations occurring at the cellular level in
response to lung toxicants.
Materials and Methods
Chemicals. We obtained dextrose from Fisher
Chemicals (Pittsburgh, PA), SeaPlaque low-
melting-point agarose from FMC Bioproducts
(Rockland, ME), and ultrapure urea from US
Biological Corp. (Cleveland, Ohio). Protease
inhibitor cocktail III was acquired from
CalBioChem (LaJolla, CA). The oxylipins
were obtained from Cayman Chemical (Ann
Arbor, MI), or synthesized in-house (Kim
et al. 2004; Newman et al. 2002; Watanabe
et al. 2003). We purchased solid phase extrac-
tion (SPE) cartridges (Oasis HLB 60 mg)
from Waters (Milford, MA) and ethyl acetate,
phosphoric acid, and glacial acetic acid of
HPLC grade or better from Fisher Scientific
(Pittsburgh, PA). Omni-Solv acetonitrile and
methanol purchased from EM Science
(Gibbstown, NJ) were used for all reverse-
phase HPLC analyses. All other chemical
reagents were purchase from Sigma Chemical
Company (St. Louis, MO). 1-NN was synthe-
sized as previously described (Crivello 1981).
Animal exposures. Male Sprague-Dawley
rats were purchased from Harlan (Indianapolis,
IN). All protocols and procedures were
approved by the University of California Davis
Animal Care and Use Committee and are in
accordance with the National Institutes of
Health Guide for the Care and Use of
Laboratory Animals (Institute of Laboratory
Animal Resources 1996) to ensure that the ani-
mals were treated humanely with regard for
alleviation of suffering. Animals were fed
ad libitum and housed in HEPA-filtered cage
racks at the University of California, Davis, in
a facility accredited by the Association for
Assessment and Accreditation of Laboratory
Animal Care. Animals were held for at least
5 days before use in an experiment. Seventy-
two rats (281–318 g body weight, 8–10 weeks
of age) were randomly assigned to 18 groups
(n = 4) (Table 1). 
Filtered air versus O3. Groups 1–9 were
exposed to filtered air for 90 days and
groups 10–18 were exposed to 0.8 ppm O3
8 hr/day for 90 days, as previously described
(Paige et al. 2000). On the 91st day all rats
were returned to ambient air, and the rats in
groups 1–3 and 10–12 received a single
intraperitoneal (ip) injection of corn oil
(vehicle).
Dose and temporal response. Groups 4–6
and 13–15 received an ip injection of 12.5
mg/kg 1-NN in corn oil. Groups 7–9 and
16–18 received an ip injection of 50 mg/kg
1-NN in corn oil. Groups 1, 4, 7, 10, 13,
and 16 were sacrificed 2 hr postinjection,
groups 2, 5, 8, 11, 14 and 17 were sacrificed
6 hr postinjection, and groups 3, 6, 9, 12, 15,
and 18 were sacrificed 24 hr postinjection.
Animals were sacrificed by a lethal dose of
pentobarbital. Time intervals were selected to
observe initial inflammatory phase, injury
phase, and repair phase. We collected bronchio-
lar lavage fluid (BLF) immediately after
euthanasia, using the lysis-lavage method as
described by Wheelock et al. (2004). Briefly,
the alveolar region was sealed off through par-
tial inflation with agarose. The airways were
then lavaged with an isotonic dextrose solu-
tion. The collected sample thus differs from
the more commonly used BALF, where both
airways and alveoli are lavaged.
Oxylipin analysis. On-line SPE extrac-
tion. Analysis of cysteinyl leukotrienes
(cys-LT) was performed by online solid phase
extraction coupled to HPLC-tandem mass
spectrometry (MS). BLF samples were diluted
1:1 with 2.5 mM phosphoric acid (pH 3.8),
and spiked with internal standard [12-(3-cyclo-
hexyl-ureido)-dodecanoic acid, 27.9 nM].
Twenty microliters of each sample was injected
on the Oasis HLB pre-column (20 mm ×
2.1 mm; Waters), which was then washed
using aqueous solvent to remove interfering
matrix components such as salts and proteins.
Following the injection and wash steps, the
pre-column was eluted in the reverse direction
onto the analytical HPLC column. Analytes
were separated on a reversed-phase HPLC col-
umn [Luna 5 µm C18 (2), 150 × 2.0 mm;
Phenomenex, Torrance, CA] using gradient
elution. Solvent A consisted of 8.3 mM acetic
acid, with the pH adjusted to 5.7 with ammo-
nium hydroxide; solvent B was acetonitrile:
methanol:acetic acid (65:35:0.1), and the flow
rate was 200 µL/min. The solvent gradient
started with 99% solvent A and 1% solvent B;
it was held for 2.2 min, then increased to 30%
solvent B and held for 4 min and further
increased to 50% solvent B for 6.5 min.
Finally, the column was washed with 100%
solvent B for 2 min, then returned to the start-
ing conditions and equilibrated for 1.5 min
before the next injection.
Off-line SPE extraction. BLF aliquots
(250 µL) were diluted 1:1 vol/vol with
2.5 mM phosphoric acid immediately before
SPE extraction. Surrogates containing
26.7 nM of 6-keto prostaglandin F1α–d4
(PGF1α–d4), 10(11)-epoxyheptadecanoic
acid, and 10,11-dihydroxynonadecanoic acid
were added to each sample before SPE was
performed. Oasis-HLB 60 mg cartridges
(Waters) were preconditioned with 2 mL of
methanol and 2 mL of 2.5 mM phosphoric
acid (pH 3.8). After the samples were applied,
the cartridges were washed with 2 mL of
2.5 mM phosphoric acid (pH 3.8). The ana-
lytes were eluted with 2 mL ethyl acetate; all
elutions were performed by gravity. The ethyl
acetate extract was evaporated under nitrogen,
and the samples were resuspended in 100 µL
methanol containing 26.7 nM of the internal
standards (1-phenyl-3-hexanoic acid urea and
1-cyclohexyl-dodecanoic acid urea). Samples
were vortexed for 5 min, transferred to
autosampler vials with low volume inserts and
stored at –20°C until analysis.
LC/MS/MS method. Liquid chromatog-
raphy/tandem MS (LC/MS/MS) analysis of
oxylipins was performed as previously
described (Schmelzer et al. 2005). We used a
Waters 2790 separation module equipped
with a 2.0 × 150 mm, 5 µm Luna C18 (2)
column (Phenomenex), and the column tem-
perature was held at 40°C. The samples were
kept at 10°C in the autosampler, and 10 µL
of each sample was injected. The solvent flow
rate was fixed at 350 µL/min. The solvent gra-
dient started with 85% water with 0.1% glacial
acetic acid (solvent A) and 15% acetonitrile:
methanol:acetic acid (88:12:0.1) (solvent B)
and was held for 30 sec. Solvent B was then
increased to 30% by 2 min, then to 55% by
8 min, and 75% by 28 min. Finally, the col-
umn was washed with 100% solvent B for
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Table 1. Exposure regimen of rats by group number. 
Filtered air O3
1-NN (mg/kg) 2 hr 6 hr 24 hr 2 hr 6 hr 24 hr
0 (vehicle) 1 2 3 10 11 12
12.5 4 5 6 13 14 15
50 7 8 9 16 17 18
Rats were sacrificed at 2, 6, or 24 hr postinjection; n =
4 rats/group.
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5 min, then returned to the starting condi-
tions and equilibrated for 5 min before the
next injection. A Quattro Ultima tandem-
quadrupole mass spectrometer (Micromass,
Manchester, UK) equipped with an electro-
spray ionization source was used in negative
ion mode. Compounds were analyzed in mul-
tiple reaction monitoring mode and quanti-
fied by using surrogate corrected calibration
curves. Calibration curves were generated by
10 µL injections of seven different calibration
standards containing each analyte, surrogate,
and internal standard. For online SPE extrac-
tion, the ionization source was used in posi-
tive ion mode, which allowed for greater
sensitivity for the cys-LTs. The cys-LT
method, which includes LTC4, LTD4, LTE4,
LTF4, and N-acetyl LTE4, was modified from
the method of Kishi et al. (2001).
Cytokine and chemokine analysis. We
purchased rat protein cytokine/chemokine-
array kits from RayBiotech (Norcross, GA).
Cytokine/chemokine analysis was performed
using BLF from a pooled sample (n = 4)
from animals that received filtered air or O3
without 1-NN, because no induction of
cytokines or chemokines was expected. BLF
from rats that received 1-NN were analyzed
with individual arrays. Briefly, the mem-
branes were blocked with a blocking buffer;
then 1 mL BLF from each treatment group
was added to the membranes, and incubated
at room temperature for an additional 2 hr.
The membranes were washed and incubated
with 1 mL primary biotin-conjugated anti-
body at room temperature for 2 hr, followed
by 2 mL horseradish peroxidase–conjugated
streptavidin at room temperature for 30 min.
The membranes were developed using ECL
Plus solution (Amersham, Piscataway, NJ)
and were exposed to Storm imager (Chemi-
fluorescent detection), and signals were ana-
lyzed using ImageQuant 5.1 software
(Molecular Dynamics, Sunnyvale, CA).
These arrays are semiquantitative; therefore,
the individual cytoines/chemokines had to be
present in 75% of the samples to be consid-
ered an increase. 
Statistical analysis. We used the Student’s
t-test to determine differences between
exposed groups and control groups. Values
with p < 0.01 were considered significant. For
statistical analysis, analytes below the limit of
detection were assigned a value at the limit of
detection.
Results and Discussion
The long-term inhalation of O3 fundamentally
alters the cellular homeostasis of the respiratory
system (Pinkerton et al. 1993). This change is
evident with a subsequent exposure to another
prevalent environmental contaminant, 1-NN;
previous pathology studies have shown that
O3-tolerant animals exhibit a dose-dependent
increased susceptibility to 1-NN (Paige et al.
2000a, 2000b). The observed synergistic
effects were localized to the central acinus, an
area that undergoes distinct biochemical and
structural changes in response to long-term O3
exposure. Specifically, 24 hr after 1-NN
administration, 17% of the distal airway
epithelium was denuded and 8% of the
remaining cells were necrotic in O3-exposed
animals at the lowest 1-NN dose tested
(50 mg/kg). In the corresponding filtered air–
exposed animals, the distal airway epithelium
remained continuous and only 6% of the cells
were necrotic (Paige et al. 2000b). At higher
1-NN doses, the synergistic effects were even
more pronounced (Paige et al. 2000b).
Although the increased toxicity to 1-NN can
be explained in part by an induced expression
of P450 2B1 in O3-tolerant animals (Paige
et al. 2000a) with subsequent alterations in the
protein adduct formation pattern (Wheelock
et al. 2005), the mechanisms underlying the
synergistic toxicity are largely unknown. The
present study was designed to investigate the
occurrence and importance of alterations in the
inflammatory response to 1-NN in O3-tolerant
animals. We found that rats exposed to O3 and
1-NN produce inflammatory mediators analo-
gous to an allergic response, whereas rats
exposed to filtered air and 1-NN produce
inflammatory mediators consistent with an
acute inflammatory response. 
O3 versus filtered air (no 1-NN exposure).
The rat respiratory system is much less sensi-
tive to O3 than that of nonhuman primates,
and exposures to concentration > 0.5 ppm are
required to mimic the pathologic effects on
the primate lung at ambient O3 concentra-
tions (Barr et al. 1990). To reflect this differ-
ence, we intentionally set the level of O3
exposure in this study (0.8 ppm) to about
twice as high as typical peak values in pol-
luted urban areas. The levels of PGE2 and
12-HETE were significantly higher in BLF
from O3-tolerant rats compared with BLF
from filtered air–exposed rats (Figure 1).
PGE2 is a potent vasodilator that can enhance
edema and leukocyte emigration. Previous
studies have shown that chronic O3 exposure
leads to an increased number of Clara cells in
the central acinus, which can produce both
PGE2 and 12-HETE (Van Scott et al. 1990).
Additionally, Marom et al. (1983) found that
12-HETE, in nanomolar concentrations, is
capable of stimulating the release of mucosal
proteins from human airways. In many air-
way diseases, mucus overproduction and cell
metaplasia are two clinical hallmarks that are
frequently associated with airway obstruction
and inflammation. Animal experiments with
O3 exposure demonstrated an increase of
mucous cell hyperplasia in the airway epithe-
lium (Paige and Plopper 1999). In the present
study, we found no significant differences in
cytokine production between filtered air– and
O3-exposed rats (data not shown).
1-NN temporal and dose response in fil-
tered air–exposed rats. In polluted urban areas,
we are exposed to low levels of 1-NN through
inhalation of both the aerosol and particulates.
Because no satisfactory regimen for inhalation
exposure to 1-NN currently is available, the
toxicant was administered through ip injection
in this study, as well as in the preceding pathol-
ogy studies (Paige and Plopper 1999; Paige
et al. 2006b). No studies correlating doses
through different administration routes have
been published for 1-NN. However, corre-
sponding studies for the parent compound
naphthalene, which has a similar mechanism of
toxicity, correlated injury levels in distal airways
following inhalation of current Occupational
Safety and Health Administration standards
(10 ppm) with ip administration of 100 mg/kg
in mice, approximately 25% of the median
lethal dose (LD50) (Warren et al. 1982; West
et al. 2001). In addition, we recently showed
that 1-NN is activated in the airway epithe-
lium before hepatic activation (also following
ip administration), and injury to the airway
epithelium is likely independent of hepatic
metabolism (Wheelock et al. 2005). In that
study, we used two doses: a low dose of
12.5 mg/kg to mimic an environmentally rele-
vant dose and a high dose of 50 mg/kg,
approximately 36% of the LD50 (Verschoyle
and Dinsdale 1990), to match previous pathol-
ogy studies. Also, we studied three different
time points. 
The profile of lipid mediators and cyto-
kines changed at each time point denoting the
inflammatory stages (i.e., injury and repair).
Figure 2 depicts five oxylipin metabolites at
the three sampling times, 2, 6, and 24 hr. The
temporal profile for the linoleic diols
[dihydroxyoctadecenoic acid (DiHOMEs)]
indicates that the greatest increase occured at
2 hr; then the concentration slowly decreased
throughout the study. A similar pattern indi-
cating injury and repair phases was displayed
by 5-HETE, but with the maximum occur-
ring at 6 hr. The 15-HETE concentration
Figure 1. Differences in the metabolites PGE2 and
12-HETE in rats exposed to O3 or filtered air for
90 days (mean ± SD ; n = 12).
*Statistically significant (p < 0.01.
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increases over time for both the 12.5 and
50 mg/kg doses, indicating that 15-HETE
may be involved with cellular proliferation and
repair phases (Kuhn 1996). PGD2 concentra-
tions reached a maximum at 6 hr postinjec-
tion, and had decreased again after 24 hr, with
a statistically significant change in the high-
dose animals (50 mg/kg) but not in the low-
dose animals (12.5 mg/kg). Finally, LTC4
constantly increased throughout the three time
points, indicating that it may be responsible for
the bronchoconstriction that occurs during the
early and late inflammatory responses. In most
instances, a dose-dependent effect in expression
levels was observed when the dose of 1-NN
was increased from 12.5 to 50 mg/kg. 
Additionally, at a 1-NN dose of 12.5
mg/kg, we detected the cytokines tumor necro-
sis factor-α (TNF-α) and interleukin-1α
(IL-1α) only at 2 hr postinjection, whereas IL-6
and IL-10 were present at 6 and 24 hr post-
injection (Supplemental Material, Table S1A,
available online at http://www.ehponline.org/
docs/2006/8373/suppl.pdf). Increasing the
1-NN dose to 50 mg/kg again increased the
inflammatory response, but with similar pro-
files. TNF-α and IL-1β were detected at 2 hr,
along with cytokine-induced neutrophil
chemoattractant-1 (CINC-2), granulocyte-
macrophage colony-stimulating factor
(GM-CSF), macrophage inflammatory pro-
tein-3α, IL-6, leptin, monocyte chemoattrac-
tant protein-1, ciliary neuronotrophic factor
(CNTF), interferon-γ (IFN-γ), and IL-10.
Data from both doses of 1-NN indicate an
acute inflammatory event, with the 50 mg/kg
dose producing more cellular injury. As time
progressed, the number of immunostimulatory
cytokines, such as TNF-α and IL-1,
decreased. TNF-α and IL-1 play a fundamen-
tal role in initiating the inflammatory cascade.
Specifically, they contribute to polymorpho-
nuclear cell maturation, trafficking, and acti-
vation. As time progresses, the number of
immunoregulatory cytokines increases, which
counteracts various aspects of inflammation.
For example, IL-10 balances this amplification
by promoting the mRNA degradation of IL-1,
IL-6, and TNF-α (Howard 1992; Malefyt
1991).
Overall, the results of the present study
were consistent with the pathologic responses
to 1-NN observed in previous studies (Paige
et al. 1997; Sauer et al. 1997). Moreover, the
sensitivity of the inflammatory mediator
analysis allowed the detection of these effects
at exposure levels as low as 12.5 mg/kg. In
contrast, animals exposed to even 25 mg
1-NN/kg are pathologically indistinguishable
from control animals (Paige et al. 1997). 
Synergistic effects of O3 and 1-NN
(12.5 mg/kg). Previous studies have shown
that long-term O3 exposure causes cellular
remodeling of the respiratory tract (Chang et al.
1992; Harkema et al. 1987; Paige and Plopper
1999; Stockstill et al. 1995). In the terminal
bronchioles, ciliated and Clara cells begin
invading the alveolar airspace. Additionally,
there is evidence of bronchiolar metaplasia of
the alveolar ducts (Pinkerton et al. 1993),
epithelial inflammation, and interstitial fibrosis.
Other cellular changes include proliferation of
type II pneumocytes (Chang et al. 1992), fibro-
sis (Stockstill et al. 1995), interstitial thickening
in the central acinus, and an increase in alveolar
macrophages (Paige and Plopper 1999).
Although this adaptation makes the lung more
resistant to further O3 insult, O3-tolerant lungs
are more susceptible to secondary lung irritants
such as 1-NN (Paige et al. 2000a, 2000b). The
results of the present study indicate that the
observed synergistic toxicity is correlated with
an altered inflammatory response of the airway.
The 12.5 mg/kg dose of 1-NN with prior O3
exposure led to a greater inflammatory response
than the same dose of 1-NN and filtered air–
exposure. Thirteen oxylipins and 11 cytokines
were statistically different in response to 1-NN
and O3 as compared with 1-NN and filtered air
(Supplemental Material, Table S1A,B; available
online at http://www.ehponline.org/docs/2006/
8373/suppl.pdf). 
DiHOMEs, 15-HETE, 11-HETE,
12-HETE, 5-HETE, 6-keto- PGF1α, throm-
boxane B2, PGE2, PGD2, and LTB4 are statis-
tically higher in O3-tolerant rats exposed to
12.5 mg/kg 1-NN, than in filtered air–exposed
animals receiving the same 1-NN dose
(Supplemental Material, Table S1B; available
Ozone-tolerant airways are more susceptible to 1-NN
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Figure 2. 1-NN exposure produced temporal changes (mean ± SD; n = 4) in BLF oxylipins derived from epoxygenase, cyclooxygenase (COX), and lipoxygenase
(LOX) pathways. All values in A–C are depicted as the percent of control rats receiving filtered air and vehicle without 1-NN. (A–C) LOX-dependent metabolites
5-HETE (A), 15-HETE (B), and LTC4 (C). (D) Epoxygenase-dependent metabolite 12,13-DiHOME. (E) COX-dependent metabolite PGD2. (F) Analyte concentrations in
rats exposed to filtered air and treated with vehicle.
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online at http://www.ehponline.org/docs/
2006/8373/suppl.pdf). Figure 2 shows com-
parisons of O3-exposed rats (dose 12.5 mg/kg
1-NN) to filtered air–exposed rats (both
12.5 and 50 mg/kg 1-NN doses). In contrast
to filtered air–exposed rats, DiHOME concen-
trations in BLF did not decrease with time but
remained elevated until the end of the experi-
ment. Sustained micromolar concentrations of
DiHOME have been observed in patients
under inflammatory and hypoxic conditions
(Dudda 1996; Ozawa et al. 1988) and cardio-
pulmonary toxicity (Hayakawa et al. 1990;
Ishizaki 1996; Ozawa et al. 1988). Similar
temporal patterns were seen for 5-HETE,
which is rapidly produced upon inflammatory
insult; 5-HETE is a potent mediator of neutro-
phil function, with chemotactic activity and
the ability to modulate lysosomal enzyme
release (Spanbroek et al. 2000). At 2 hr after
1-NN administration, the 15-HETE concen-
tration was significantly higher in O3-tolerant
rats than in filtered air–exposed rats; by 24 hr,
the 15-HETE level was significantly lower
than in the filtered air–exposed rats adminis-
tered 1-NN. Bronchial mucosal biopsies from
asthma patients are known to have increased
levels of 15-lipoxygenase, the enzyme that pro-
duces 15-HETE (Bradding 1995). In the pre-
sent study, O3-tolerant rats given 1-NN
showed an initial increase in PGD2 concentra-
tion, but by 24 hr the PGD2 concentrations
were no longer statistically different from fil-
tered air–exposed rats administered 1-NN.
The major source of PGD2 is activated mast
cells, which contribute significantly to broncho-
constriction, airway hyperreactivity, and
inflammation (Kleeberger et al. 2001). The
most striking differences are seen in the cys-LTs
at 2, 6, and 24 hr (Figure 2 and Supplemental
Material, Table S1B; available online at http://
www.ehponline.org/docs/2006/8373/suppl.
pdf). The cys-LTs contract smooth muscle of
the airway (Barnes et al. 1984), act on the vas-
culature to produce vasodilation, and increase
vascular permeability (Drazen et al. 1980).
Additionally, cys-LTs stimulate mucous secre-
tion and interfere with mucociliary clearance
(Marom et al. 1982). It is widely believed that
cys-LTs are important mediators in bronchial
asthma. Furthermore, increased LTB4 and
cys-LT levels have been found in human BALF
after O3 exposure (Coffey et al. 1996). Sources
of cys-LT production include eosinophils, mast
cells, and macrophages. Under certain condi-
tions, mast cells produce and release IL-4,
which plays an important role in the differenti-
ation and maturation of T cells towards the
T helper (TH) 2 phenotype. 
The synergistic effects of O3 and 1-NN
were most apparent when examining the
cytokine/chemokine arrays 2 hr postexposure
(Figure 3). In comparison, at 6 hr post-
exposure, no pathologic signs of synergistic
toxicity can be observed with 50 mg/kg
1-NN (Lee MG, personal communication).
Figure 3A shows the absence of inflammatory
cytokines in control rats exposed to filtered air
and vehicle. Figure 3B indicates the presence
of TNF-α, and IL-1β in a rat exposed to fil-
tered air and 12.5 mg/kg 1-NN. Figure 3C
depicts the presence of cytokines/chemokines—
including IL-10 and CNTF, which are
immunoregulatory and counteract various
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Figure 3. BLF chemokine/cytokine profiles of rats exposed to different doses of 1-NN ± O3 at the 2-hr time point.
Abbreviations: LIX, LPS inducing factor; MCP, monocyte chemoattractant protein; MIP, macrophage inflammatory
protein; TIMP, tissue inhibitor of metalloproteinases; VEGF, vascular endothelial growth factor. Circled regions in
the upper left and lower right portions of the arrays indicate positive and negative controls, whereas the rectan-
gles indicate cytokines that showed selective responses to 1-NN ± O3. (A) Control rats (n = 4, pooled sample; expo-
sure group 1, filtered air without 1-NN). (B) Individual rat (exposure group 4, filtered air and 12.5 mg/kg 1-NN).
(C) Individual rat (exposure group 7, filtered air and 50 mg/kg 1-NN). (D) Individual rat (exposure group 13, O3-toler-
ant rats exposed to 12.5 mg/kg 1-NN). Analysis of the arrays revealed an increase in levels of certain cytokines and
chemokines in response to different concentrations of 1-NN (B,C). An individual cytokine/chemokine had to be pre-
sent in 75% of the samples to be considered increased; for example IFN-γ is visable in (D) but was not present in
75% of the samples, and is therefore not considered increased above control. Also, a different set of
cytokines/chemokines are present in (D). (A–D) are representative of multiple experiments, all of which gave simi-
lar results. (E) Array map for the panel of 19 secreted cytokines/chemokines from Ray Biotec. In (C) and (D), the
boxes indicate the cytokines and chemokines that differ in response to 50 mg/kg 1-NN plus filtered air exposure
(gray boxes in C and E) or 12.5 mg/kg 1-NN plus O3 exposure (blue boxes in D and E), No statistical significance
was found in animal weight or in BLF protein concentration among the various groups (p < 0.05).
A B
C D
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aspects of inflammation—in a rat exposed to
filtered air and 50 mg/kg 1-NN. Figure 3D
depicts immunostimulatory mediators includ-
ing β-nerve growth factor (β-NGF), IL-1α,
CINC-3, and IL-4 and an increase in GM-CSF
in a rat exposed to O3 and 12.5 mg/kg 1-NN.
Moreover, there are no immunoregulatory
cytokines/chemokines present in Figure 3D.
The abundance of seven cytokines/chemokines
were different in O3-tolerant rats administered
12.5 mg/kg 1-NN compared with rats exposed
to filtered air and 50 mg/kg 1-NN. The O3-tol-
erant rats produced a unique cytokine profile
that is comparable with an influx of TH2 cells
and eosinophils and the development of airway
hyperresponsiveness. The TH2 inflammatory
event is characterized by an increase in IL-4,
IL-5, GM-CSF, and β-NGF (Bosson et al.
2003; Braun et al. 1998; Driscoll et al. 1993;
Ishii et al. 1997; Maggi et al. 1992; Sanico et al.
2000; Spanbroek et al. 2000; Stankova et al.
1995). IL-4 stimulates B cells to produce anti-
gen-specific IgE and inhibits the production of
TH1 cytokines such as IFN-γ (Maggi et al.
1992). IFN-γ was not detected in the O3-
tolerant rats, but it was detected in filtered air–
exposed rats given 50 mg/kg 1-NN. Although
we did not measure IL-5, previous work has
shown that O3 increases the amount of IL-5
and GM-CSF (Joad et al. 1994). These pro-
teins promote the recruitment, activation, and
survival of eosinophils. Activated eosinophils
are primed for the enhanced production of
cys-LT, which may be a major source of the
hyperresponsiveness. Finally, β-NGF alters
sensory nerve function and promotes allergic
inflammation, bronchial hyperactivity, and
airway obstruction (Quarcoo et al. 2004). 
The ability of O3 to enhance allergic sensi-
tization in mice has been well documented.
Exposures in mice of O3 > 0.13 ppm showed
greater anaphylactic sensitivity to intravenous
challenge with ovalbumin (Gershwin et al.
1981). Increases in mediators important in
inflammation, such as IL-6, IL-5, GM-CSF,
and PGE2, have also been documented in
BALF recovered from humans exposed to O3
(Bosson et al. 2003; Devlin et al. 1996; Joad
et al. 1994). Our results in the present study
illustrate that the interaction between O3 and
1-NN alters the inflammatory response in a
way that would not have been predicted from
individual toxicologic profiles. Tolerance to O3
is associated with increased activity of several
antioxidant enzymes (Plopper et al. 1994) and
elevated levels of glutathione (Duan et al.
1996). Although the electrophilic 1-NN
metabolites supposedly are detoxified by gluta-
thione conjugation (Watt et al. 1999), this
reaction does not impart total resistance to
1-NN (Paige et al. 2000a, 2000b). Our data
suggest that O3-tolerant rats produce an aller-
gic inflammatory response upon exposure to
1-NN, which may explain the mechanisms
underlying the unexpected enhanced sensitivity
to 1-NN. The mechanism by which O3
remodeling establishes the TH2-mediated aller-
gic inflammation is unknown. This might
result from the direct effect of O3 on increasing
membrane permeability, allowing toxicants to
penetrate deeper into tissue or allowing more
leukocytes into the lungs. Additionally, O3
may modulate the local cytokine milieu within
the airways through the enhanced recruitment
of leukocytes into the lung, such as mast cells
and eosinophils, which produce IL-4.
Alternatively, O3 may also have a direct effect
on the process of allergic sensitization by modi-
fying proteins in antigen-presenting cells that
function within airways.
Conclusion
In this study we examined mechanisms under-
lying the synergistic toxicity between O3 and
1-NN by analyzing the differences in inflam-
matory profiles. The inflammatory profile
consisted of 35 oxylipin metabolites and
19 different cytokines. Filtered air and O3-
tolerant rats were exposed to 1-NN at three
different doses (0, 12.5, and 50 mg/kg), and
BLF was collected at three different time
points. The present study demonstrates a sensi-
tive method to detect differences in inflamma-
tory responses and provides further evidence
that O3 adaptation produces an allergen-like
immune response to 1-NN even at relatively
low doses (12.5 mg/kg). Further investigations
are now required to determine whether similar
profiles can be found in human patients
exposed to such co-pollutants.
The synergism of O3 and 1-NN is proba-
bly due to the remodeling that occurs after
long-term O3 exposure. This remodeling
appears to establish a TH2 inflammatory
response rather than a TH1 response seen in fil-
tered air–exposed controls. The alteration in
cytokine/chemokine data, along with the high
concentration of cys-LT, provides strong sup-
port for this argument. BLF from rats exposed
to O3 and 12.5 mg/kg 1-NN contained IL-4,
GM-CSF, β-NGF, TNF-α, IL-1, and a high
concentration of LTC4 (923% of control). The
same dose administered to filtered air–exposed
rats produces only increases in TNF-α, IL-1α,
and LTC4 (120% of control).
Currently, ambient air quality standards
(U.S. EPA 2000) are based on the toxicologic
effects of a single pollutant (e.g., O3).
Consequently, the health risk of breathing a
mixture of pollutants may have been under-
estimated. Although extrapolating such experi-
mental data to human exposures should be
done with great caution, our findings suggest
that cellular and biochemical changes associated
with chronic oxidant stress, frequently encoun-
tered in highly polluted areas, may significantly
elevate susceptibility to some co-pollutants,
thereby posing a greater risk to human health.
REFERENCES
Atkinson R, Arey J. 1994. Atmospheric chemistry of gas-phase
polycyclic aromatic hydrocarbons: formation of atmospheric
mutagens. Environ Health Perspect 102(suppl 4):117–126.
Balmes JR, Aris RM, Chen LL, Scannell C, Tager IB, Finkbeiner
W, et al. 1997. Effects of ozone on normal and potentially
sensitive human subjects. Part I: airway inflammation and
responsiveness to ozone in normal and asthmatic sub-
jects. Res Rep Health Eff Inst(78):1–37.
Barnes NC, Piper PJ, Costello JF. 1984. Comparative effects of
inhaled leukotriene C4, leukotriene D4, and histamine in
normal human subjects. Thorax 39(7):500–504.
Barr BC, Hyde DM, Plopper CG, Dungworth DL. 1990. A
comparison of terminal airway remodeling in chronic daily
versus episodic ozone exposure. Toxicol Appl Pharmacol
106:384–407.
Bosson J, Stenfors N, Bucht A, Helleday R, Pourazar J,
Holgate ST, et al. 2003. Ozone-induced bronchial epithelial
cytokine expression differs between healthy and asthmatic
subjects. Clin Exp Allergy 33(6):777–782.
Bradding P, Redington AE, Djukanovic R, Conrad DJ, and
Holgate ST. 1995. 15-Lipoxygenase immunoreactivity in
normal and in asthmatic airways. Am J Respir Crit Care
Med 151:1201–1204.
Braun A, Appel E, Baruch R, Herz U, Botchkarev V, Paus R,
et al. 1998. Role of nerve growth factor in a mouse model
of allergic airway inflammation and asthma. Eur J Immunol
28(10):3240–3251.
Chang LY, Huang Y, Stockstill BL, Graham JA, Grose EC,
Menache MG, et al. 1992. Epithelial injury and interstitial
fibrosis in the proximal alveolar regions of rats chronically
exposed to a simulated pattern of urban ambient ozone.
Toxicol Appl Pharmacol 115(2):241–252.
Coffey MJ, Wheeler CS, Gross KB, Eschenbacher WL, Sporn PH,
Peters-Golden M. 1996. Increased 5-lipoxygenase metabo-
lism in the lungs of human subjects exposed to ozone.
Toxicology 114(3):187–197.
Connor LM, Ballinger CA, Albrecht TB, Postlethwait EM. 2004.
Interfacial phospholipids inhibit ozone-reactive absorption-
mediated cytotoxicity in vitro. Am J Physiol Lung Cell Mol
Physiol 286(6):L1169–1178.
Crivello JV. 1981. Nitrations and oxidations with inorganic nitrate
salts in trifluoroacetic anhydride. J Org Chem 46:3056–3062.
Devlin RB, McDonnell WF, Becker S, Madden MC, McGee MP,
Perez R, et al. 1996. Time-dependent changes of inflamma-
tory mediators in the lungs of humans exposed to 0.4 ppm
ozone for 2 hr: a comparison of mediators found in broncho-
alveolar lavage fluid 1 and 18 hr after exposure. Toxicol
Appl Pharmacol 138(1):176–185.
de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE.
1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by
human monocytes: an autoregulatory role of IL-10 produced
by monocytes. J Exp Med 174:1209–1220.
Draper W. 1986. Quantitation of nitro- and dinitropolycyclic aro-
matic hydrocarbons in diesel exhaust particulate matter.
Chemosphere 15:437–447.
Drazen JM, Austen KF, Lewis RA, Clark DA, Goto G, Marfat A,
et al. 1980. Comparative airway and vascular activities of
leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad
Sci USA 77(7):4354–4358.
Driscoll KE, Simpson L, Carter J, Hassenbein D, Leikauf GD. 1993.
Ozone inhalation stimulates expression of a neutrophil
chemotactic protein, macrophage inflammatory protein 2.
Toxicol Appl Pharmacol 119(2):306–309.
Duan X, Buckpitt AR, Pinkerton KE, Ji C, Plopper CG. 1996. Ozone-
induced alterations in glutathione in lung subcompartments
of rats and monkeys. Am J Respir Cell Mol Biol 14(1):70–75.
Dudda A, Spiteller G, Kobelt F. 1996. Lipid oxidation products in
ischemic porcine heart tissue. Chem Phys Lipids 82:39–51.
Gauderman WJ, Avol E, Gilliland F, Vora H, Thomas D, Berhane K,
et al. 2004. The effect of air pollution on lung development
from 10 to 18 years of age. N Engl J Med 351(11):1057–1067.
Gershwin LJ, Osebold JW, Zee YC. 1981. Immunoglobulin E-
containing cells in mouse lung following allergen inhala-
tion and ozone exposure. Int Arch Allergy Appl Immunol
65(3):266–277.
Harkema JR, Plopper CG, Hyde DM, St George JA, Wilson DW,
Dungworth DL. 1987. Response of the macaque nasal
epithelium to ambient levels of ozone. A morphologic and
morphometric study of the transitional and respiratory
epithelium. Am J Pathol 128(1):29–44.
Hayakawa M, Kosaka K, Sugiyama S, Yokoo K, Aoyama H,
Ozone-tolerant airways are more susceptible to 1-NN
Environmental Health Perspectives • VOLUME 114 | NUMBER 9 | September 2006 1359
Schmelzer et al.
1360 VOLUME 114 | NUMBER 9 | September 2006 • Environmental Health Perspectives
Izawa Y, et al. 1990. Proposal of leukotoxin, 9,10-epoxy-12-
octadecenoate, as a burn toxin. Biochem Int 21(3):573–579.
Hiltermann TJ, Peters EA, Alberts B, Kwikkers K, Borggreven
PA, Hiemstra PS, et al. 1998. Ozone-induced airway
hyperresponsiveness in patients with asthma: role of
neutrophil-derived serine proteinases. Free Radic Biol
Med 24(6):952–958.
Howard M. 1992. Biological properties of interleukin 10. J Clin
Immunol 12:239–247.
Institute of Laboratory Animal Resources. 1996. Guide for the
Care and Use of Laboratory Animals. 7th ed. Washington,
DC:National Academy Press.
Ishihara Y, Kagawa J. 2003. Chronic diesel exhaust exposures
of rats demonstrate concentration and time-dependent
effects on pulmonary inflammation. Inhal Toxicol
15:473–492.
Ishii Y, Yang H, Sakamoto T, Nomura A, Hasegawa S, Hirata F,
et al. 1997. Rat alveolar macrophage cytokine production
and regulation of neutrophil recruitment following acute
ozone exposure. Toxicol Appl Pharmacol 147(2):214–223.
Ishizaki T, Shigemori K, Ameshim S, Nakai T, Miyabo S,
Hayakawa M, et al. 1996. Protective effects of BQ-123, an
ETA receptor antagonist, against leukotoxin-induced injury
in rat lungs. Am J Physiol 271:L459–L463.
Joad JP, McDonald RJ, Giri SN, Bric JM. 1994. Ozone effects on
mechanics and arachidonic acid metabolite concentrations
in isolated rat lungs. Environ Res 66(2):186–197.
Kelly FJ, Mudway I, Krishna MT, Holgate ST. 1995. The free
radical basis of air pollution: focus on ozone. Respir Med
89(10):647–656.
Kim IH, Morisseau C, Watanabe T, Hammock BD. 2004.
Design, synthesis, and biological activity of 1,3-disubsti-
tuted ureas as potent inhibitors of the soluble epoxide
hydrolase of increased water solubility. J Med Chem
47(8):2110–2122.
Kishi N, Mano N, Asakawa N. 2001. Direct injection method for
quantitation of endogenous leukotriene E4 in human urine
by liquid chromatography/electrospray ionization tandem
mass spectrometry with a column-switching technique.
Anal Sci 17(6):709–713.
Kleeberger SR, Ohtsuka Y, Zhang LY, Longphre M. 2001. Airway
responses to chronic ozone exposure are partially mediated
through mast cells. J Appl Physiol 90(2):713–723.
Kuhn H. 1996. Biosynthesis, metabolization and biological
importance of the primary 15-lipoxygenase metabolites
15-hydro(pero)XY-5Z,8Z,11Z,13E-eicosatetraenoic acid and
13-hydro(pero)XY-9Z,11E-octadecadienoic acid. Prog Lipid
Res 35(3):203–226.
Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni MP,
Rugiu FS, et al. 1992. Reciprocal regulatory effects of IFN-γ
and IL-4 on the in vitro development of human Th1 and Th2
clones. J Immunol 148(7):2142–2147.
Marom Z, Shelhamer JH, Bach MK, Morton DR, Kaliner M.
1982. Slow-reacting substances, leukotrienes C4 and D4,
increase the release of mucus from human airways
in vitro. Am Rev Respir Dis 126(3):449–451.
Marom Z, Shelhamer JH, Sun F, Kaliner M. 1983. Human airway
monohydroxyeicosatetraenoic acid generation and mucus
release. J Clin Invest 72(1):122–127.
Newman JW, Watanabe T, Hammock BD. 2002. The simultaneous
quantification of cytochrome P450 dependent linoleate and
arachidonate metabolites in urine by HPLC-MS/MS. J Lipid
Res 43 (9):1563–1578.
Ozawa T, Sugiyama S, Hayakawa M, Satake T, Taki F, Iwata M,
et al. 1988. Existence of leukotoxin 9,10-epoxy-12-octa-
decenoate in lung lavage from rats breathing pure oxygen
and from patients with the adult respiratory distress syn-
drome. Am Rev Respir Dis 137(3):535–540.
Paige RC, Plopper CG. 1999. Acute and chronic effects of ozone
in animal models. In: Air Pollution and Health (Holgate ST,
Samet JM, Koren HS, Maynard RL, eds). London:Academic
Press, 531–557.
Paige RC, Royce FH, Plopper CG, Buckpitt AR. 2000a. Long-term
exposure to ozone increases acute pulmonary centriacinar
injury by 1-nitronaphthalene: I. Region-specific enzyme
activity. J Pharmacol Exp Ther 295(3):934–941.
Paige RC, Wong V, Plopper CG. 1997. Dose-related airway-
selective epithelial toxicity of 1-nitronaphthalene in rats.
Toxicol Appl Pharmacol 147(2):224–233.
Paige RC, Wong V, Plopper CG. 2000b. Long-term exposure to
ozone increases acute pulmonary centriacinar injury by
1-nitronaphthalene: II. Quantitative histopathology.
J Pharmacol Exp Ther 295 (3):942–950
Pinkerton KE, Dodge DE, Cederdahl-Demmler J, Wong VJ,
Peake J, Haselton CJ, et al. 1993. Differentiated bronchiolar
epithelium in alveolar ducts of rats exposed to ozone for
20 months. Am J Pathol 142(3):947–956.
Plopper CG, Chu FP, Haselton CJ, Peake J, Wu J, Pinkerton KE.
1994a. Dose-dependent tolerance to ozone. I. Tracheo-
bronchial epithelial reorganization in rats after 20 months’
exposure. Am J Pathol 144(2):404–420.
Plopper CG, Duan X, Buckpitt AR, Pinkerton KE. 1994b. Dose-
dependent tolerance to ozone. IV. Site-specific elevation in
antioxidant enzymes in the lungs of rats exposed for 90 days
or 20 months. Toxicol Appl Pharmacol 127:124–131
Pryor WA. 1994. Mechanisms of radical formation from reac-
tions of ozone with target molecules in the lung. Free
Radic Biol Med 17(5):451–465.
Pulfer MK, Taube C, Gelfand E, Murphy RC. 2005. Ozone exposure
in vivo and formation of biologically active oxysterols in the
lung. J Pharmacol Exp Ther 312(1):256–264.
Putman E, van Golde LM, Haagsman HP. 1997. Toxic oxidant
species and their impact on the pulmonary surfactant
system. Lung 175(2):75–103.
Quarcoo D, Schulte-Herbruggen O, Lommatzsch M, Schierhorn
K, Hoyle GW, Renz H, et al. 2004. Nerve growth factor
induces increased airway inflammation via a neuro-
peptide-dependent mechanism in a transgenic animal
model of allergic airway inflammation. Clin Exp Allergy
34(7):1146–1151.
Sanico AM, Stanisz AM, Gleeson TD, Bora S, Proud D,
Bienenstock J, et al. 2000. Nerve growth factor expression
and release in allergic inflammatory disease of the upper
airways. Am J Respir Crit Care Med 161(5):1631–1635.
Sauer JM, Eversole RR, Lehmann CL, Johnson DE, Beuving LJ.
1997. An ultrastructural evaluation of acute 1-nitro-
naphthalene induced hepatic and pulmonary toxicity in
the rat. Toxicol Lett 90(1):19–27.
Schlesinger RB, Driscoll KE, Gunnison AF, Zelikoff JT. 1990.
Pulmonary arachidonic acid metabolism following acute
exposures to ozone and nitrogen dioxide. J Toxicol
Environ Health 31(4):275–290. 
Schmelzer KR, Kubala L, Newman JW, Kim IH, Eiserich JP,
Hammock BD. 2005. Soluble epoxide hydrolase is a thera-
peutic target for acute inflammation. Proc Natl Acad Sci
USA 102(28):9772–9777.
Spanbroek R, Hildner M, Steinhilber D, Fusenig N, Yoneda K,
Radmark O, et al. 2000. 5-Lipoxygenase expression in den-
dritic cells generated from CD34(+) hematopoietic progeni-
tors and in lymphoid organs. Blood 96(12):3857–3865.
Stankova J, Rola-Pleszczynski M, Dubois CM. 1995. Granulocyte-
macrophage colony-stimulating factor increases 5-lipoxy-
genase gene transcription and protein expression in human
neutrophils. Blood 85(12):3719–3726.
Stockstill BL, Chang LY, Menache MG, Mellick PW, Mercer RR,
Crapo JD. 1995. Bronchiolarized metaplasia and interstitial
fibrosis in rat lungs chronically exposed to high ambient
levels of ozone. Toxicol Appl Pharmacol 134(2):251–263.
U.S. Environmental Protection Agency (EPA). 2000. Air Quality
and Emission Trends Report. Research Triangle Park,
NC:U.S. Environmental Protection Agency. 
van Bree L, Dormans JA, Boere AJ, Rombout PJ. 2001. Time
study on development and repair of lung injury following
ozone exposure in rats. Inhal Toxicol 13(8):703–718.
Van Scott MR, McIntire MR, Henke DC. 1990. Arachidonic acid
metabolism and regulation of ion transport in rabbit Clara
cells. Am J Physiol 259(4 Pt 1):L213–L221.
Verschoyle RD, Carthew P, Wolf CR, Dinsdale D. 1993.
1-Nitronaphthalene toxicity in rat lung and liver: effects of
inhibiting and inducing cytochrome P450 activity. Toxicol
Appl Pharmacol 122:208–213.
Verschoyle RD, Dinsdale D. 1990. Protection against chemical-
induced lung injury by inhibition of pulmonary cytochrome
P-450. Environ Health Perspect 85:95–100.
Warren DL, Brown DL Jr, Buckpitt AR. 1982. Evidence for
cytochrome P-450 mediated metabolism in the bronchiolar
damage by naphthalene. Chem Biol Interact 40:287–303.
Watanabe T, Morisseau C, Newman JW, Hammock BD. 2003.
In vitro metabolism of the mammalian soluble epoxide
hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea. Drug
Metab Dispos 31(7): 846–853.
Watt KC, Morin DM, Kurth MJ, Mercer RS, Plopper CG,
Buckpitt AR. 1999. Glutathione conjugation of electrophilic
metabolites of 1-nitronaphthalene in rat tracheobronchial
airways and liver: identification by mass spectrometry and
proton nuclear magnetic resonance spectroscopy. Chem
Res Toxicol 12:831–839.
West JA, Pakehham G, Morin D, Fleschner CA, Buckpitt AR,
Plopper CG. 2001. Inhaled naphthalene causes dose
dependent Clara cell cytotoxicity in mice but not in rats.
Toxicol Appl Pharmacol 173:114–119
Wheelock AM, Boland BC, Isbell M, Morin D, Wegesser TC,
Plopper CG, Buckpitt AR. 2005. In vivo effects of ozone
exposure on protein adduct formation by 1-nitronaphtha-
lene in rat lung. Am J Respir Cell Mol Biol 33(2):130–137. 
Wheelock AM, Zhang L, Tran MU, Morin D, Penn S, Buckpitt
AR, et al. 2004. Isolation of rodent airway epithelial cell
proteins facilitates in vivo proteomics studies of lung toxi-
city. Am J Physiol Lung Cell Mol Physiol 286(2):L399–L410.
